REMEDIUMREMEDIUM1561-59362658-3534Joint-Stock Company Chicot145010.32687/1561-5936-2022-26-3-225-228Original ArticlePharmacy tourism and reimport of medical products as a form of ensuring the availability of medicinesAnanchenkovaP. I.ananchenkova@yandex.ruN. A. Semashko National Research Institute of Public HealthScientific Research Institute of Healthcare Organization and Medical Management of the Department of Healthcare of the City of Moscow1512202226322522821092022Copyright © 2022,2022The article examines the features of the development of pharmacy tourism as a form of medical tourism and the reimport of medicines that ensure their availability in conditions of dysfunctionality of national health systems in ensuring the right of patients to medical care. The conclusion is made that pharmacy tourism contributes to compensating for the high cost of medicines in the country of residence, simplifying the organizational and regulatory system for obtaining the right to purchase medicines; ensures the availability of drugs in their physical absence in the distribution system.tourismpharmacy tourismreimportavailability of medicinesтуризмаптечный туризмреимпортдоступность лекарственных средств[Hogerzeil H. V. Essential medicines and human rights: what can they learn from each other? // Bull. World Health Organ. 2006. Vol. 84, N 5. P. 371-375. DOI: 10.2471/blt.06.031153][Duong M., Moles R. J., Chaar B. et al. Essential medicines in a high income country: essential to whom? // PLoS ONE. 2015. Vol. 10, N 12. P. e0143654. DOI: 10.1371/journal.pone.0143654][Hedman L. Global approaches to addressing shortages of essential medicines in health systems // WHO Drug Information. 2016. Vol. 30, N 2. P. 180.][Besançon L., Chaar B. Report of the International Summit on Medicines Shortage: Toronto, Canada, 20-21 June 2014.][Ананченкова П. И., Камынина Н. Н. Социально-экономические аспекты развития экспорта медицинских услуг // Проблемы социальной гигиены, здравоохранения и истории медицины. 2020. T. 28, № 2. P. 184-189. DOI: 10.32687/0869-866X-2020-28-2-184-189][Ананченкова П. И., Камынина Н. Н. Некоторые аспекты развития медицинского и лечебно-оздоровительного туризма // Проблемы социальной гигиены, здравоохранения и истории медицины. 2020. Т. 28, № 4. С. 605-609. DOI: 10.32687/0869-866X-2020-28-4-605-609][Safran D. G., Neuman P., Schoen C. et al. Prescription drug coverage and seniors: how well are states closing the gap? // Health Aff. (Millwood). 2002. Suppl. Web Exclusives. Р. W253-W268. DOI: 10.1377/hlthaff.w2.253.][Wagner J. L., McCarthy E.International differences in drug prices // Annu. Rev. Public Health. 2004. Vol. 25. P. 475-495. DOI: 10.1146/annurev.publhealth.25.101802.123042][Vivian J. C. Canadian drug imports. US Pharmacists. 2003. Vol. 28: 7.][Danzon P. M., Kim J. D.International price comparisons for pharmaceuticals. Measurement and policy issues // Pharmacoeconomics. 1998. Vol. 14, Suppl. 1. P. 115-128. DOI: 10.2165/00019053-199814001-00014][Meadows M. Imported drugs raise safety concerns // FDA Consumer magazine. 2002. Vol. 36, N 5. P. 18-23.][World Health Organization. A study on the public health and socioeconomic impact of substandard and falsified medical products. Geneva; 2017.][Vickers S., Bernier M., Zambrzycki S. et al. Field detection devices for screening the quality of medicines: a systematic review // BMJ Global Health. 2018. Vol. 3, N 4. P. e000725. DOI: 10.1136/bmjgh-2018-000725][Lundin S., Liu R. «Where and how do you buy medicines?». A pilot survey of consumption strategies among the public in Sweden //j. Public Health. 2020. Vol. 42, N 3. P. e268-e271. DOI: 10.1093/pubmed/fdz075]